Close menu




Comments

Photo credits: pixabay.com

Commented by Fabian Lorenz on July 31st, 2024 | 06:45 CEST

Nel, Bitcoin Group, VCI Global with Super Micro Computer: Shares on the verge of a mega rally?

  • Software
  • AI
  • chips
  • Bitcoin

The Nel share is driving not only investors to despair but also analysts. While some see 100% upside potential, others are advising investors to sell. And what is the Bitcoin Group doing? After tripling in value, the crypto exchange's share price has corrected significantly in recent weeks. Will the operating figures bring new momentum? VCI Global aims to benefit even more from the boom in artificial intelligence. To meet the demand for computing power, the Company, listed on the NASDAQ and in Frankfurt, plans to set up an AI data centre in Malaysia by mid-2025. Among its partners is the AI heavyweight Super Micro Computer, with chips likely to come from NVIDIA.

Read

Commented by André Will-Laudien on July 30th, 2024 | 07:00 CEST

Olympic turnaround expected: TUI and Lufthansa bombed out, dynaCERT on the move, and BayWa poised for a comeback!

  • Hydrogen
  • greenhydrogen
  • Travel
  • Sustainability

When shares fall sharply, there are often fundamental reasons, but sometimes the story is misunderstood by investors, and both scenarios can occur simultaneously. In the case of the tourism shares TUI and Lufthansa, it is noticeable that the share prices are going nowhere in the middle of the holiday season. Are there still skeletons in the closet? BayWa is at least making some headway but is dangerously overindebted. The hydrogen specialist dynaCERT now has all the pieces of the puzzle together, and significant movement is expected soon. We provide deeper insights for your portfolio strategy.

Read

Commented by Armin Schulz on July 30th, 2024 | 06:45 CEST

thyssenkrupp, Globex Mining, Barrick Gold - Which share holds the most potential?

  • Mining
  • Gold
  • Commodities
  • Copper

In the midst of a turbulent phase on the global markets, companies in the commodities sector are facing enormous challenges. Recent developments have increased volatility, as evidenced by the unexpectedly strong growth in China's commodity imports in July. Despite these positive signals, the market reaction has been subdued, partly due to negative indicators like the falling copper price. Copper serves as an early indicator of global economic strength. Investors eagerly await a potential rebound while market observers discuss the causes and future opportunities. Today, we will look at a steel, mining, and gold company to determine which one holds the most potential.

Read

Commented by Stefan Feulner on July 30th, 2024 | 06:30 CEST

Viking Therapeutics, Vidac Pharma, Merck KGaA - In the footsteps of Novo Nordisk

  • Biotechnology
  • Biotech
  • Pharma

Drugs for the treatment of diabetes and obesity have helped the pharmaceuticals manufacturer Novo Nordisk to become the most valuable listed company in Europe. But the competition is not sleeping. Many promising biotechs are already presenting new preparations that could overtake the Danes in the long term. Young companies with the chance of the next blockbuster also have great potential in other areas, such as cancer research.

Read

Commented by Stefan Feulner on July 29th, 2024 | 06:45 CEST

Riot Platforms, Desert Gold Ventures, British American Tobacco with a bang

  • Mining
  • Gold
  • Bitcoin
  • consumergoods

Summer is in its hot phase, and there is no sign that the global stock markets are cooling down. On the contrary, with the US election campaign entering a new round following Joe Biden's withdrawal, the presidential candidates are trying to mobilize voters. One target group that Donald Trump was able to win over at the weekend is that of crypto enthusiasts. In a fiery speech at Bitcoin 2024 in Nashville, he emphasized that Bitcoin would rise like never before under his presidency.

Read

Commented by André Will-Laudien on July 29th, 2024 | 06:30 CEST

Here we go! Olympic 250% with hydrogen! Nel, Plug Power, First Hydrogen, thyssenkrupp and nucera

  • Hydrogen
  • greenhydrogen
  • Sustainability
  • Electromobility

Olympia goes Hydrogen! Japanese car manufacturer Toyota is providing a fleet of 500 Mirai hydrogen vehicles, 10 hydrogen buses, and 1,150 electric vehicles for the Olympic Games in Paris. Although hydrogen vehicles, such as the Toyota Mirai, produce virtually no emissions, 96% of the hydrogen produced worldwide still comes from fossil fuels such as methane gas. As a result, most hydrogen vehicles currently cause significantly more pollution than battery-powered electric vehicles and are only marginally cleaner than conventional combustion engines. However, there are notable exceptions: First Hydrogen is demonstrating how things could work in the future with the EU's 'Net Zero 2050' target!

Read

Commented by André Will-Laudien on July 25th, 2024 | 08:20 CEST

BioNTech, CureVac, Bayer, Cardiol Therapeutics, and Evotec: Tripled and still in turbo mode?

  • Biotechnology
  • Biotech
  • Pharma

On the stock market, separating the wheat from the chaff is essential, especially in the biotech sector. This task becomes challenging when ongoing studies conclude, and their results must be interpreted. The market does not always react correctly to announcements, as evidenced by this year's acquisition of MorphoSys. While the stock market rejected the supposedly poor results, Novartis built up the first favourable positions, ultimately acquiring the Munich-based company for EUR 2.7 billion. From a low of around EUR 12, the acquisition price was a high EUR 68, making it a 500% deal. But opportunities are always lurking. Here is a selection of promising candidates.

Read

Commented by Juliane Zielonka on July 25th, 2024 | 07:45 CEST

Plug Power, Carbon Done Right, BASF: Raising capital, climate protection projects, and cost optimization for returns

  • Sustainability
  • CarbonCredits
  • renewableenergies
  • Hydrogen
  • chemicals

The energy sector is undergoing radical change, with far-reaching consequences for companies across various sectors. The hydrogen specialist Plug Power is struggling with financial bottlenecks despite state subsidies and has to carry out a capital increase on unfavourable terms. The sustainability company Carbon Done Right reports initial successes with its reforestation project in Sierra Leone. The Canadians are thus further establishing themselves in the growing market for CO₂ certificates. The chemical and agricultural company BASF is responding to the changing conditions in Germany by closing plants. The energy transition requires not only technological innovations but also new business models and flexible adaptation strategies. Which of the three companies will win the race this time?

Read

Commented by André Will-Laudien on July 24th, 2024 | 07:00 CEST

Averting power outages, starting the battery revolution! BASF, Altech Advanced Materials, BYD, and VW

  • Batteries
  • Hydrogen
  • BatteryMetals
  • Electromobility
  • renewableenergies

Varta is undergoing a complete restructuring and reorganization, likely leaving legacy shareholders empty-handed. The back and forth since 2023 has given the German SME sector an increasingly unsettling look. The environment is challenging, and only the strongest will survive the looming storm. Traces of Habeck's poor planning can also be seen in the energy transition. Instead of fully utilizing renewable energies, six new gas-fired power plants are now being planned, which will, of course, be powered by hydrogen. This draws investors' attention back to battery storage systems, as they are needed to successfully store surplus energy. Where do the opportunities lie for resourceful investors?

Read

Commented by Fabian Lorenz on July 24th, 2024 | 06:30 CEST

BioNTech, Bayer, Vidac Pharma: Buy recommendations and potential worth billions

  • Biotechnology
  • Pharma
  • Biotech

Can BioNTech shares stop the downward trend? A "Buy" recommendation gives hope. According to this recommendation, the shares of the German biotech flagship have the potential to double in value. Analysts believe a multiplication is possible for Vidac Pharma. The biotech company is pursuing a revolutionary approach in the fight against cancer, and the first drug has a revenue potential of over EUR 1 billion. Even though research is still ongoing, Vidac is not expensive with a market capitalization of less than EUR 10 million, and is a takeover candidate if the study data remain positive. Analysts do not currently see any impetus for an increase in Bayer's share price. However, shareholders should be ready for news from the pharmaceutical pipeline in the coming weeks. These are important for the DAX-listed company.

Read